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Introduction {#sec1}
============

Vertebrate embryonic development involves stepwise cell-fate conversion events. Neural induction is one of the most critical developmental events occurring during gastrulation, whereby a subset of epiblast cells acquires a neuroectodermal fate ([@bib30]). Neuroectodermal cells develop into all of the regional neural progenitors and ultimately the brain and spinal cord; thus, a failure of neural induction results in severe neural tube defects (NTDs) ([@bib7]). Ninety percent of affected pregnancies will be terminated ([@bib12]), with the survivors facing a risk of prenatal to postnatal lethality or lifelong disability, including neurological and cognitive complications. However, knowledge pertaining to abnormal neural induction in NTDs remains limited.

Previous studies have revealed that the suppression of bone morphogenetic protein (BMP) pathways and coordinated regulation of the fibroblast growth factor (FGF), transforming growth factor β, and calcineurin signaling pathways are central to the extrinsic control of neural induction ([@bib5], [@bib20], [@bib28]). These extracellular signals subsequently converge on specific lineage-determining transcription factors to regulate neural induction. For example, BMP/SMAD signaling suppresses commitment to the neural lineage via the induction of ID proteins ([@bib35]). The FGF-ERK1/2-PARP1 cascade directly activates *Pax6* expression to advance human neuroectodermal specification ([@bib37], [@bib39]). Various transcription factors have also been found to lead undifferentiated cells to adopt a neural fate intrinsically. The zinc-finger nuclear protein *Zfp521* is required and sufficient to drive the intrinsic transition of embryonic stem cell (ESC) differentiation into neuroectodermal cells ([@bib15]). The POU domain transcription factor *Oct6* initiates internal neural induction programs by directly activating neural-lineage genes, such as *Zfp521* and *Pax6* ([@bib42]), when expressed in the epiblast and the early neuroectoderm during development ([@bib43]). Disruption of the hierarchies of these signaling or gene-regulatory networks during early embryonic development may underlie abnormal neural induction in NTDs. Although NTDs have long been proposed to be primarily triggered by external environmental stresses, the specific environmental sensors that function to translate these environmental stresses into intracellular gene-regulatory network activity during the neural induction stage remain largely unexplored.

*Sirt1*, a conserved NAD^+^-dependent lysine deacetylase, has been reported to be an environmental sensor that mediates intracellular responses to environmental states, such as redox state, nutrient availability, and DNA damage, in various organisms. In response to DNA damage or oxidative stress, *Sirt1* is activated to repress *p53*-dependent apoptosis in mammalian cells ([@bib22]), nuclear p53-mediated transactivation of proapoptotic genes in mouse cells ([@bib9]), and FOXO3-induced cell death in human cells ([@bib2]). Starvation-induced SIRT1 activation is required for the initiation of autophagy to cope with the lack of external nutrients in eukaryotes ([@bib3], [@bib19]). Recently, *Sirt1* was also found to be required to suppress neurogenesis or to induce oligodendrogenesis in neural stem/progenitor cells ([@bib26], [@bib29]), suggesting a profound role for *Sirt1* during neural development.

Here, we report that environmental stresses activate SIRT1, which further deacetylates OCT6 and triggers an OCT6 ubiquitination/degradation cascade. Given that Oct6 is a crucial neural fate inducer during neural induction, environmental stress-triggered dysregulation of the SIRT1/OCT6 axis will therefore lead to neural induction defects and NTD-like phenotypes.

Results {#sec2}
=======

Early Maternal Exposure to Resveratrol Induces NTD-like Phenotypes in Mouse Embryos {#sec2.1}
-----------------------------------------------------------------------------------

SIRT1 has long been thought to be activated by environmental stresses to promote the survival of adult cells ([@bib3], [@bib16]). As a potent SIRT1 activator, resveratrol (RSV) has been used to reveal various noteworthy features of SIRT1 deacetylase activity during numerous biological processes, including neurodegeneration and senescence ([@bib25], [@bib33]). To mimic environmental stress-induced SIRT1 activation during early neural development, we subjected pregnant mice to daily intragastric administration of RSV (25 mg/kg/day) between gestational day 3.5 (GD3.5) and GD10.5. When euthanized at GD10.5, 37.1% of the embryos that were exposed to RSV treatment displayed clear neurological malformations, exhibiting either a smaller brain size or increased indentations between the prosencephalon/metencephalon or metencephalon/spinal cord ([Figures 1](#fig1){ref-type="fig"}A, 1D, [S1](#mmc1){ref-type="supplementary-material"}A, and S1B). No obvious morphological changes related to the heart primordium or the limb buds were found. Histological analysis and staining for SOX1 and NESTIN showed that the entire neural tube was severely misshapen and the neurocoele became smaller; these phenotypes resembled NTDs ([Figures 1](#fig1){ref-type="fig"}B and 1C). Consistent with the NTD phenotype, the expression of NTD-risk genes (*Gcn5*, *Folr1*, *Eya1*, *Six1*, *Alx1*, *Zic2*, *Acat2*, etc.) also showed obvious downregulation in the RSV-treated embryos ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D), which is consistent with their lower expression pattern or loss-of-function mutations in other NTD models or NTD patients ([@bib8], [@bib10], [@bib13]). Moreover, the expression of typical neural-lineage genes (*Sox1*, *Pax6*, and *N-cadherin*) was lower in RSV-treated embryos ([Figure 1](#fig1){ref-type="fig"}E). Even when the dosage of RSV was reduced to 7.5 mg/kg/day, 25% of the embryos still exhibited NTD-like phenotypes ([Figures 1](#fig1){ref-type="fig"}A, 1D, and [S1](#mmc1){ref-type="supplementary-material"}A). Increasing the dosage to 125 mg/kg/day increased the incidence of NTD-like phenotypes to 52.9% ([Figures 1](#fig1){ref-type="fig"}A, 1D, and [S1](#mmc1){ref-type="supplementary-material"}A). Similar results were obtained when RSV was intraperitoneally injected at GD3.5 until GD10.5 ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F). These data suggest that SIRT1 activation plays a detrimental role in early embryonic neural tube development.

RSV Causes NTD-like Phenotypes in Teratomas {#sec2.2}
-------------------------------------------

The teratoma formation assay is another in vivo system that mimics early embryonic development. We subcutaneously injected mouse ESCs (mESCs) into NOD/SCID mice, followed by daily intragastric administration of RSV. Teratomas formed within 3--4 weeks and were then harvested for histological and mRNA analysis. Histological analysis and SOX1 immunostaining showed that teratomas from the RSV-treated group presented minimal neural tube-like structures ([Figures 1](#fig1){ref-type="fig"}F and 1G). mRNA analysis also revealed that neural-lineage genes were expressed at lower levels ([Figure 1](#fig1){ref-type="fig"}H). In contrast, hallmark genes for pluripotency, endoderm, epidermis, and trophectoderm (*Nano*g, *Gata4*, *Gata6*, *K18*, *K19*, and *Lamb1*) were all upregulated ([Figures 1](#fig1){ref-type="fig"}I, [S1](#mmc1){ref-type="supplementary-material"}G, and S1H). These results support a reduction of neural-lineage generation and a similar NTD-like phenotype in these RSV-treated teratomas.

RSV Hinders the Neural Induction of mESCs and Induced Epiblast Stem Cells In Vitro {#sec2.3}
----------------------------------------------------------------------------------

To confirm the influence of SIRT1 activation on neural development, we selected a well-accepted system for the neural differentiation of mESCs in vitro involving serum-free cultured embryoid-body aggregates (SFEBs) ([@bib32]). Using this system, mESCs were efficiently converted to a neural fate. This result was demonstrated by the sequential downregulation and activation of pluripotent genes, epiblast genes, neural-lineage genes, and neuronal genes during neural differentiation ([Figure S2](#mmc1){ref-type="supplementary-material"}A). In addition, as 46C is a *Sox1*-*GFP* reporter line ([@bib36]), GFP expression faithfully recapitulated endogenous *Sox1* expression and indicated a committed neural fate ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). All of these observations suggest the usefulness of this in vitro differentiation system for mimicking dynamic neural developmental events.

When RSV was applied to neural differentiation medium, the generation of GFP^+^ neural-lineage cells was severely compromised in a dose-dependent manner ([Figures 2](#fig2){ref-type="fig"}A, 2B, and [S2](#mmc1){ref-type="supplementary-material"}D). Immunostaining assays confirmed the reduced percentage of SOX1-GFP^+^/N-CADHERIN^+^ or SOX1^+^/NESTIN^+^ neural stem/progenitor cells generated in the RSV-treated group ([Figures 2](#fig2){ref-type="fig"}C, [S2](#mmc1){ref-type="supplementary-material"}E, and S2F). qPCR analysis revealed that *Sox1*, *Zfp521*, *Pax6*, *Nestin*, and *N-cadherin* mRNA levels were all significantly reduced after RSV treatment ([Figure 2](#fig2){ref-type="fig"}D). We also confirmed that RSV treatment slightly affected the apoptosis or cell cycle of differentiated mESCs ([Figures S2](#mmc1){ref-type="supplementary-material"}G and S2H). Additionally the mRNA levels of pluripotent genes (*Nanog* and *Rex1*), epiblast genes (*Fgf5* and *Dnmt3b*), mesodermal genes (*Mixl1* and *Flk1*), endodermal genes (*Gata4* and *Gata6*), trophectodermal genes (*Cdx2* and *Lamb1*), and epidermal genes (*K18* and *K19*) were all increased after RSV treatment ([Figure S2](#mmc1){ref-type="supplementary-material"}I). Similar results were obtained in another mESC line, R1 ([Figures S2](#mmc1){ref-type="supplementary-material"}J and S2K). These data suggest that early exposure to SIRT1 activation preferentially hinders the neural-lineage specification of mESCs by maintaining mESCs in a pluripotent state or forcing the cells to adopt a non-neural fate in vitro.

To identify the SIRT1 activation-sensitive stage during neural differentiation, we applied RSV to differentiated mESCs at different time points until day 5, when the mESCs were mostly committed to neural progenitors under normal differentiation conditions. The most significant suppression of neural differentiation was achieved when RSV was added from day 0, 1 or 2, but not afterward ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). Short-term RSV treatment from days 0--3 or days 2--3 also significantly inhibited neural differentiation ([Figures S3](#mmc1){ref-type="supplementary-material"}D--S3F). These data suggest that differentiated mESCs are most sensitive to SIRT1 activation on days 2--3, defined as the neural induction period. Furthermore, similar neural induction defects were observed when RSV was applied to induced epiblast stem cells (EpiSCs) ([Figures 2](#fig2){ref-type="fig"}E--2J). These results demonstrate that SIRT1 activation specifically hinders the neural induction process.

RSV Inhibits the Neural Induction of mESCs in a SIRT1 Deacetylase Activity-Dependent Manner {#sec2.4}
-------------------------------------------------------------------------------------------

To confirm the role of SIRT1 deacetylase activity in RSV treatment-induced neural induction defects, we first treated mESCs with RSV for 1.5 or 2.5 days under differentiation conditions and then collected the cells for western blotting. A remarkable decrease in the levels of acetylated H4K16 and H3K9, the two best-known SIRT1 histone targets, was observed after RSV treatment, whereas no obvious influences on other potential targets of RSV (e.g., GSK3β or ERK1/2 signaling) were detected ([Figure 3](#fig3){ref-type="fig"}A). We also immunoprecipitated SIRT1 from day-2.5 SFEBs in the absence or presence of RSV treatment, and examined SIRT1 deacetylase activity. The results showed that SIRT1 deacetylase activity was upregulated by more than 7-fold after RSV exposure, without obvious changes in SIRT1 protein levels ([Figures 3](#fig3){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}A). Furthermore, as we expected, activating SIRT1 deacetylase using another potent activator, SRT1720, similarly inhibited the neural differentiation of 46C mESCs ([Figures 3](#fig3){ref-type="fig"}C, 3D, and [S4](#mmc1){ref-type="supplementary-material"}B). These observations prove that SIRT1 deacetylase activation is sufficient to trigger neural induction defects.

Next, we used two efficient short hairpin RNAs (shRNAs) against the coding region of *Sirt1* to knock down *Sirt1*, along with a control shRNA against *Luciferase* (sh*Luc*) ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D). sh*Luc* and sh*Sirt1* mESCs were then subjected to neural differentiation for 5 days in the absence or presence of RSV treatment. Similar to wild-type mESCs, RSV-treated sh*Luc* mESCs showed a lower efficiency of neural induction ([Figures 3](#fig3){ref-type="fig"}E--3H), whereas *Sirt1* knockdown clearly potentiated the efficiency of neural induction in both the absence and presence of RSV treatment ([Figures 3](#fig3){ref-type="fig"}E--3H and [S4](#mmc1){ref-type="supplementary-material"}E--S4G). Considering the pattern of decreased *Sirt1* expression during normal neural differentiation ([Figures S4](#mmc1){ref-type="supplementary-material"}H and S4I), we revealed that the downregulation of SIRT1 deacetylase activity is a prerequisite for the efficient conversion of pluripotent stem cells to a neural fate during gastrulation. Through CRISPR/Cas9-mediated homologous recombination, we further integrated CAG promoter-driven wild-type *Sirt1* or a deacetylase-inactive *Sirt1* mutant (*Sirt1* H355A) into the *Hprt* locus for constitutive overexpression in mESCs ([@bib6], [@bib18], [@bib20]). The overexpression efficiency was examined by qPCR and western blotting ([Figures S4](#mmc1){ref-type="supplementary-material"}J and S4K). Overexpressing wild-type *Sirt1* significantly retarded neural induction, whereas overexpressing the *Sirt1* H355A mutant slightly potentiated rather than suppressed the efficiency of neural induction ([Figures 3](#fig3){ref-type="fig"}I--3L). Collectively our results indicate that RSV hinders the neural induction of mESCs in a SIRT1 deacetylase activity-dependent manner.

SIRT1 Directly Targets OCT6 and Then Activates Its Deacetylation/Ubiquitination/Degradation Cascade {#sec2.5}
---------------------------------------------------------------------------------------------------

Neural induction is tightly controlled by key neuroectodermal transcription factors, including *Sox2*, *Otx2*, *Zic2*, *Pax6*, and *Oct6* ([@bib1], [@bib24], [@bib39], [@bib41], [@bib42]). To determine which transcription factors were responsible for the SIRT1 activation-induced neural induction defects, we overexpressed these transcription factors in RSV-treated mESCs, whereby only *Oct6* overexpression improved the neural induction efficiency ([Figures 4](#fig4){ref-type="fig"}A--4C and [S5](#mmc1){ref-type="supplementary-material"}A). Given that *Oct6* initiates the neural induction program via direct activation of *Zfp521*, we found that overexpression of *Zfp521* completely rescued the neural induction defects triggered by RSV treatment ([Figures S5](#mmc1){ref-type="supplementary-material"}B--S5D), indicating that the *Oct6*/*Zfp521* axis may be responsible for the SIRT1 activation-triggered neural induction defects. Interestingly, examining the mRNA and protein levels of *Oct6* revealed that RSV markedly downregulated OCT6 protein expression, while the mRNA level remained unchanged ([Figures 4](#fig4){ref-type="fig"}D and 4E). Moreover, OCT6 enrichment in the enhancer regions of hallmark neural-lineage genes such as *Zfp521* and *Pax6* was also significantly decreased after RSV treatment ([Figure 4](#fig4){ref-type="fig"}F). These data suggested that SIRT1 activation might decrease OCT6 protein stability at the post-translational level, which thereby leads to the neural induction defects. To this end, we examined OCT6 expression levels in sh*Sirt1* mESCs and found that *Sirt1* knockdown upregulated OCT6 protein levels, but not *Oct6* mRNA levels, in mESCs ([Figures 4](#fig4){ref-type="fig"}G and [S5](#mmc1){ref-type="supplementary-material"}E) and rescued RSV-triggered OCT6 downregulation ([Figures 4](#fig4){ref-type="fig"}H and [S5](#mmc1){ref-type="supplementary-material"}F). Furthermore, overexpression of wild-type *Sirt1* but not the deacetylase-inactive mutant (*Sirt1* H355A) decreased OCT6 protein expression ([Figures 4](#fig4){ref-type="fig"}I and [S5](#mmc1){ref-type="supplementary-material"}G). All of these data suggest that the deacetylase activity of SIRT1 is negatively correlated with OCT6 protein stability.

Pretreatment with a potent proteasome inhibitor, MG132, stabilized OCT6 protein expression in the presence of RSV treatment ([Figure 4](#fig4){ref-type="fig"}J), indicating that the ubiquitin-proteasome pathway is involved in RSV-triggered OCT6 degradation. Immunoprecipitation using an acetylated lysine (Ac-Lys) antibody was then performed in day-2.5 SFEBs after pretreatment with MG132, for which the results showed that the acetylation of OCT6 was eliminated by RSV treatment ([Figure 4](#fig4){ref-type="fig"}K). In addition, RSV treatment induced robust ubiquitination of OCT6 ([Figure 4](#fig4){ref-type="fig"}L), consistent with the hypothesis that SIRT1 activation triggers the deacetylation/ubiquitination/degradation cascade of OCT6.

To verify the physical interaction between SIRT1 and OCT6, we pulled down endogenous SIRT1 in day-2.5 SFEBs and performed western blotting, which showed substantial amounts of OCT6 in the immunocomplexes ([Figure 4](#fig4){ref-type="fig"}M). Overexpression of *Flag*-tagged *Sirt1* and *hemagglutinin* (*HA*)-tagged *Oct6* in HEK 293FT cells also revealed strong binding of exogenous SIRT1 and OCT6 ([Figure 4](#fig4){ref-type="fig"}N). Moreover, SIRT1 H355A mutant showed an efficient interaction with OCT6 ([Figure 4](#fig4){ref-type="fig"}N), indicating that the deacetylase activity of SIRT1 is not required for the physical interaction between SIRT1 and OCT6, whereas the overexpression of wild-type SIRT1 resulted in significant deacetylation of OCT6 compared with the overexpression of the SIRT1 H355A mutant in HEK 293FT cells ([Figure 4](#fig4){ref-type="fig"}O). Furthermore, when the OCT6 K263&268Q mutant, which mimics constitutively acetylated OCT6 by mutating the two putative SIRT1-deacetylated lysine residues to glutamine, was overexpressed along with differentiation, RSV treatment failed to interfere with the neural induction of mESCs ([Figures S5](#mmc1){ref-type="supplementary-material"}H--S5J). These data confirm that SIRT1 directly targets and deacetylates OCT6 to activate its ubiquitination/degradation cascade.

Oct6 Is Required for Neural Induction {#sec2.6}
-------------------------------------

A previous study established that mESCs in which *Oct6* is knocked down tend to show decreased neural fate commitment ([@bib42]). To confirm that *Oct6* indeed plays an essential role in neural induction, we generated *Oct6*^−/−^ mESCs via CRISPR/Cas9-mediated open reading frame deletion ([@bib21]) ([Figure S5](#mmc1){ref-type="supplementary-material"}K). Knockout efficiency was confirmed via genomic DNA PCR, western blotting, and qPCR ([Figures S5](#mmc1){ref-type="supplementary-material"}K--S5N). After being subjected to neural differentiation, the *Oct6*^−/−^ mESCs failed to efficiently convert to neuroectodermal cells, as demonstrated by much lower GFP induction and the reduced expression of neural-lineage-specific genes ([Figures S5](#mmc1){ref-type="supplementary-material"}O--S5Q). In addition, reintroducing *Oct6* into the *Oct6*^−/−^ mESCs rescued the neural induction efficiency ([Figures S5](#mmc1){ref-type="supplementary-material"}O--S5Q), confirming that the neural induction defects are correlated with a lack of OCT6 expression. As described above, *Sirt1* knockdown in 46C mESCs potentiated neural induction. We next knocked down *Sirt1* in *Oct6*^−/−^ mESCs and found that *Sirt1* knockdown failed to ameliorate the neural induction defects ([Figure S5](#mmc1){ref-type="supplementary-material"}R). These results provide further evidence that OCT6 acts as a downstream target of SIRT1 and that the SIRT1/OCT6 axis determines neural induction from pluripotent stem cells.

The SIRT1/OCT6 Axis Is Responsible for Environmental Stress-Induced Neural Induction Defects {#sec2.7}
--------------------------------------------------------------------------------------------

Epidemiological studies have implied that environmental stresses might serve as risk factors for NTDs ([@bib27]). To examine whether environmental stresses indeed affect neural development, we treated mESCs with the reactive oxygen species inducer H~2~O~2~ or the DNA damage inducer hydroxyurea (HU), or starved cells via glucose withdrawal for 24 hr during the neural induction stage (approximate neural differentiation days 1.5--2.5). Remarkably, all of these environmental stresses significantly hindered neural induction and instead forced mESCs to adopt a non-neural fate or maintained the cells in a pluripotent stage under differentiation conditions ([Figures 5](#fig5){ref-type="fig"}A--5C and [S6](#mmc1){ref-type="supplementary-material"}A). Considering that SIRT1 is usually activated by environmental stresses, we first analyzed SIRT1 deacetylase activity after stimulation to determine whether these environmental stresses interfered with neural induction by targeting the SIRT1/OCT6 axis. As with RSV treatment, SIRT1 deacetylase activity was significantly elevated under all the examined environmental stress conditions ([Figures 5](#fig5){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}B). Western blotting showed that H~2~O~2~, HU, and glucose starvation also greatly downregulated OCT6 protein levels, but not its transcript ([Figures 5](#fig5){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}C). Next, we studied the effects of H~2~O~2~ and HU exposure, as well as glucose starvation, in sh*Sirt1* mESCs. In contrast to the sh*Luc* mESCs, sh*Sirt1* mESCs normally differentiated into neuroectodermal cells when challenged with these environmental stresses ([Figures 5](#fig5){ref-type="fig"}F, 5G, and [S6](#mmc1){ref-type="supplementary-material"}D). Similarly, ectopic *Oct6* expression also ameliorated the neural induction defects induced by these environmental stresses ([Figures 5](#fig5){ref-type="fig"}H, 5I, and [S6](#mmc1){ref-type="supplementary-material"}E). Taken together, these results confirm that the SIRT1/OCT6 axis is responsible for the neural induction defects triggered by these environmental stresses.

Environmental Stresses Equally Target the SIRT1/OCT6 Axis and Retard Neural Induction in Human Embryonic Stem Cells {#sec2.8}
-------------------------------------------------------------------------------------------------------------------

To determine whether environmental stresses also target the SIRT1/OCT6 axis and thereby cause neural induction defects in humans, we performed teratoma formation assays by injecting human ESCs (hESCs) into the immunodeficient mice in the absence or presence of daily RSV administration (50 mg/kg/day intragastrically). After 2 months, teratomas were harvested for histological and mRNA analysis. Similar to the data obtained from mouse teratomas, we found that neural-lineage induction was significantly hindered and that the populations of other layers as well as pluripotent cells were elevated after RSV administration ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7C).

Next, we employed our well-established neural differentiation paradigm ([@bib4], [@bib38]), with which hESCs can be efficiently converted into neuroectodermal cells uniformly expressing *Sox1*, *Sox2*, *Nestin*, and *N-cadherin* ([Figures 6](#fig6){ref-type="fig"}A and 6B, left panel). Supplementing the differentiation medium with RSV severely retarded the expression of all of these neural-lineage genes at both the protein and mRNA levels, with elevated expression of other non-neural-lineage genes ([Figures 6](#fig6){ref-type="fig"}A--6C and [S7](#mmc1){ref-type="supplementary-material"}D). Consistently, RSV treatment markedly elevated SIRT1 deacetylase activity ([Figures 6](#fig6){ref-type="fig"}D and [S7](#mmc1){ref-type="supplementary-material"}E) and decreased *Oct6* expression at the protein level rather than the mRNA level ([Figures 6](#fig6){ref-type="fig"}E and [S7](#mmc1){ref-type="supplementary-material"}F). All of these results suggest that the role of the SIRT1/OCT6 axis is potentially conserved between mice and humans. To this end, we knocked out *Sirt1* in hESCs via the CRISPR/Cas9 system ([@bib21]) ([Figure S7](#mmc1){ref-type="supplementary-material"}G) and subjected the cells to neural differentiation. Accordingly, we observed dramatically elevated OCT6 protein levels in *Sirt1*^−/−^ hESCs during the early neural differentiation stage, when no OCT6 protein was detected in wild-type hESCs ([Figure 6](#fig6){ref-type="fig"}F). As neural differentiation proceeded, improved neural induction efficiency was observed in *Sirt1*^−/−^ hESCs ([Figure 6](#fig6){ref-type="fig"}G). We next induced the neural induction of *Sirt1*^−/−^ hESCs in the presence of RSV treatment. Accordingly, *Sirt1*^−/−^ hESCs were resistant to the RSV-induced degradation of OCT6 protein and underwent normal neural induction under RSV exposure ([Figures 6](#fig6){ref-type="fig"}H and 6I). In addition, *Sirt1* overexpression, H~2~O~2~ or HU treatment, and glucose starvation retarded the neural induction of hESCs in similar fashion ([Figures 6](#fig6){ref-type="fig"}J, 6K, [S7](#mmc1){ref-type="supplementary-material"}H, and S7I). Collectively these observations suggest that the functional role of the SIRT1/OCT6 axis, which is responsible for environmental stress-triggered neural induction defects, is conserved between mice and humans.

The Functional Role of the SIRT1/OCT6 Axis in Environmental Stress-Induced NTDs during Early Embryogenesis {#sec2.9}
----------------------------------------------------------------------------------------------------------

To confirm the physiological relevance of the SIRT1/OCT6 pathway in vivo, we first stained GD3.5 and GD6.5 embryos for SIRT1 and OCT6 and found that OCT6 protein levels were greatly upregulated at GD6.5 during normal gastrulation, which was accompanied by a significant decrease in SIRT1 expression ([Figures 7](#fig7){ref-type="fig"}A and 7B). In addition, *Sirt1*^+/−^ embryos (*Sirt1*^fl/fl^ mice crossed with *EIIa-Cre* mice) showed an obvious elevation in OCT6 protein levels ([Figure 7](#fig7){ref-type="fig"}C), indicating that SIRT1 negatively regulates OCT6 during normal embryonic development. To verify the role of SIRT1 in RSV-induced NTD-like phenotypes, we treated wild-type and *Sirt1*^+/−^ embryos with RSV from GD3.5 to GD10.5. We found that 29.4% of wild-type embryos displayed NTD-like phenotypes, compared with only 5.8% of Sirt1^+/−^ embryos ([Figure 7](#fig7){ref-type="fig"}D). Similarly, OCT6 protein levels were significantly decreased in wild-type embryos, whereas this decrease was obviously compromised in *Sirt1*^+/−^ embryos at GD6.5 ([Figure 7](#fig7){ref-type="fig"}E).

Interestingly, brain-specific heterozygous *Sirt1* knockout embryos (*Sirt1*^fl/fl^ mice crossed with *Nestin-Cre* mice) showed a similar incidence of NTD-like phenotypes in wild-type embryos after maternal RSV administration ([Figure 7](#fig7){ref-type="fig"}D). *Nestin* is a neural-lineage-specific gene that is activated at approximately GD7.5. We then applied RSV starting at different gestational days until GD10.5. The results showed that RSV exposure from GD3.5, GD4.5, GD5.5, and GD6.5, but not afterward, efficiently induced NTD-like phenotypes; a single RSV administration at GD6.5 also induced NTD-like phenotypes ([Figure 7](#fig7){ref-type="fig"}F). Together, these results demonstrate that RSV/SIRT1/OCT6 pathway-triggered NTDs occur early on during neural induction, before the neural lineages have been specified. Indeed, we observed overlapping SIRT1 and OCT6 expression, the physical interaction between these two proteins, as well as the acetylation of OCT6 protein, at this developmental stage ([Figures 7](#fig7){ref-type="fig"}B, 7G, and [S7](#mmc1){ref-type="supplementary-material"}J).

To recapitulate the functional role of the SIRT1/OCT6 pathway in environmental stress-induced NTDs, we employed radiation-induced NTDs as a pathophysiologically relevant in vivo model for NTDs. After 4 Gy radiation at GD5.5, 28.5% of wild-type embryos displayed NTD-like phenotypes, compared with only 6.8% of *Sirt1*^+/−^ embryos ([Figures 7](#fig7){ref-type="fig"}H and [S7](#mmc1){ref-type="supplementary-material"}K). Furthermore we found that after irradiation, OCT6 protein levels were significantly decreased in wild-type embryos, whereas this decrease was obviously compromised in *Sirt1*^+/−^ embryos at GD6.5 ([Figure 7](#fig7){ref-type="fig"}I). Collectively, these data support the pathophysiological role of the SIRT1/OCT6 axis in environmental stress-induced NTDs ([Figure 7](#fig7){ref-type="fig"}J).

Discussion {#sec3}
==========

In this study, we report an evolutionarily conserved SIRT1/OCT6 axis that is involved in abnormal neural induction in NTDs. RSV, oxidative stresses, starvation, and DNA damage inducers all activate SIRT1 deacetylase activity, which radically deacetylates OCT6 and triggers its ubiquitination/degradation cascade. Importantly, the dysregulation of the SIRT1/OCT6 axis will thereby induce NTD-like phenotypes in mice or hinder the neural induction of both hESCs and mESCs. Collectively, our data shed light on a pathophysiologically relevant role of the SIRT1/OCT6 axis in environmental stress-induced NTDs.

Annually, more than 300,000 neonates are born with NTDs worldwide. The risk of NTDs has long been proposed to be increased by environmental stresses, including maternal starvation, fever, and exposure to radiation or other teratogens, while the potential messenger between environmental stresses and NTDs remains unknown. SIRT1 has been reported to regulate the fate decision of neural stem/progenitor cells in response to environmental stimuli ([@bib29]). However, NTDs arise when the process of neural tube formation is disrupted, which is an early developmental event. Therefore, whether SIRT1 is involved in environmental stress-induced NTDs remained to be explored. Our study strongly suggests that SIRT1 deacetylase activity is greatly modified by environmental stresses and is responsible for environmental stress-induced abnormal neural induction within the in vitro neural differentiation system of both hESCs and mESCs. Furthermore, in an in vivo radiation-induced NTD model, our results indicated that *Sirt1* very likely translates environmental signals in developing embryos during early neural development and that SIRT1 activation critically contributes to environmental stress-induced NTDs.

Direct competition between lysine acetylation and ubiquitination has been proposed as a major mechanism regulating protein stability and has primarily been documented in cancer progression. p53, E2F1, SKP2, and MSH2 have been reported to be regulated by lysine acetylation and ubiquitination, which play important roles in DNA repair and tumorigenesis ([@bib14], [@bib17], [@bib31], [@bib40]). Recently, the functional relationship between acetylation and ubiquitination was assessed in a study of TAU-mediated neurodegeneration disorders ([@bib23]). However, little is known about the role of this post-translational interrelationship in early developmental events, because these events are mostly thought to be transcriptionally regulated. In the present study we discovered the inverse expression of SIRT1 and OCT6, and the active competition between OCT6 acetylation and ubiquitination during mouse gastrulation and the in vitro neural differentiation of both hESCs and mESCs. Notably, we identified a direct physical interaction between SIRT1 and OCT6 both in vivo and in vitro. Although the details regarding the specific OCT6 lysine residues that become acetylated or ubiquitinated remain to be further elucidated, the present study clearly demonstrates that active competition between OCT6 acetylation and ubiquitination is indispensable for normal neural induction.

Mammalian embryonic development is a highly coordinated set of processes involving dramatic but regular changes in the architecture of both the transcriptome and proteome. Previous reports have demonstrated that although the majority of human stage-specific gene expression modules are notably preserved in mouse embryos, the developmental specificity and timing dramatically differ between human and mouse ([@bib34]). Species differences in embryonic development, especially neural induction ([@bib39]), make animal models suboptimal for studying the etiology and pathology of developmental disorders, including NTDs. In the present study, we clearly identified the direct activation of SIRT1 deacetylase activity upon environmental stress treatment and the resulting degradation of OCT6 protein via deacetylation/ubiquitination cascade during mouse neural differentiation and gastrulation. Importantly, we recapitulated the functional interplay between SIRT1 and OCT6 during human neural induction and found that it coincides exactly with the results from mice. Collectively, our data demonstrated that the developmental role of the SIRT1/OCT6 axis is evolutionarily conserved in both humans and mice; thus, a mouse model targeting the SIRT1/OCT6 axis will facilitate the study of abnormal neural induction in NTDs triggered by environmental stresses. Finally, the regulation of the SIRT1/OCT6 axis may serve as a target for preventing these devastating neurodevelopmental disorders.
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Animal Studies {#sec4.1}
--------------

All procedures involving animals were approved by the Laboratory Animal Care Committee of Tongji University under the Guide for the Care and Use of Laboratory Animals (NIH Guide). All mice were maintained in a pathogen-free environment throughout the experiments, and all efforts were made to minimizing the number of animals used and their suffering.

mESC Culture and Neural Differentiation {#sec4.2}
---------------------------------------

mESC lines 46C (kindly provided by Austin Smith\'s laboratory) and R1 (American Type Culture Collection) were maintained on irradiated mouse embryonic fibroblasts with leukemia inhibitory factor (1,000 U/mL, Millipore). For neural differentiation, mESCs were seeded at a density of (5 ± 1) × 10^4^ cells/mL in GK8 medium, as described previously ([@bib32]). All the cells were free of mycoplasma contamination.

Induced EpiSC Generation and Neural Differentiation {#sec4.3}
---------------------------------------------------

For generation of induced EpiSCs, mESCs were plated at a density of (5 ± 1) × 10^4^ cells/mL in laminin-coated plates as described previously ([@bib11]). For neural differentiation, induced EpiSC clones were dissociated and resuspended in GK8 medium.

hESC Culture and Neural Differentiation {#sec4.4}
---------------------------------------

The culture and neural differentiation of hESCs (H9, WA09, passages 25--45, WiCell Agreement No. 14-W0377) were performed as described previously ([@bib38]).

mRNA Extraction and qPCR {#sec4.5}
------------------------

Total RNAs were isolated from the desired cells using the TRIzol (Invitrogen), reverse transcribed into cDNA using SuperScript III First-Strand Synthesis System (Invitrogen), and subjected to qRT-PCR (Bio-Rad, CFX Connect Real-Time System) with the SYBR Premix Ex Taq (TakaRa). The primers used for qPCR are listed in [Table S1](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis {#sec4.6}
--------------------

All statistical data are presented as the mean ± SEM of at least three independent experiments. Statistical significance was determined using unpaired two-tailed Student\'s t tests, except when specially noted otherwise.
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![RSV Induces NTD-like Phenotypes In Vivo\
(A) Maternal intragastric (i.g.) RSV delivery from GD3.5 to GD9.5 induces dose-dependent NTD-like phenotypes in GD10.5 embryos. Red arrowheads indicate the prosencephalon/metencephalon and metencephalon/spinal cord junctions (also shown in B).\
(B and C) Representative H&E staining (B) and SOX1 and NESTIN immunostaining (C) in frozen sections from the embryos in (A).\
(D) Incidence of NTD-like phenotypes is positively correlated with RSV dosage.\
(E) Neural-lineage gene expression between normal and RSV-induced NTD-like embryos.\
(F) Teratomas obtained from mice after intragastric RSV administration show fewer neural tube-like structures. Red arrowheads indicate the neural tube-like structures.\
(G) SOX1 staining of the teratomas in (F).\
(H and I) Neural-lineage genes are expressed at lower levels in RSV-treated teratomas (H), but the expression of non-neural-lineage genes is upregulated (I).\
Data are shown as means ± SEM of at least three independent experiments. The Chi-square test was used in (D), and unpaired two-tailed Student\'s t test was used in (H) and (I). n.s. (not significant), p \> 0.05; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the control. Scale bars, 100 μm.](gr1){#fig1}

![RSV Hinders the Neural Differentiation of mESCs and Induced EpiSCs In Vitro\
(A and B) RSV (15 μM) treatment severely compromises the production of GFP^+^ neural-lineage cells from mESCs, as shown by microscopy (A) and FACS (B) analysis in day-5 SFEBs.\
(C) N-CADHERIN and GFP immunostaining of the cells in (A).\
(D) RSV inhibits the expression of neural-lineage genes during the neural differentiation of mESCs.\
(E) Schematic representation of the generation of induced EpiSCs and targeted neural differentiation in vitro.\
(F) qPCR analysis of inner-cell-mass and epiblast markers between mESCs and induced EpiSCs.\
(G and H) RSV treatment (15 μM) severely compromises the production of neural-lineage cells from induced EpiSCs, as shown by microscopy (G) and FACS (H) analysis in day-3 SFEBs from induced EpiSCs.\
(I) RSV inhibits the expression of neural-lineage genes during the neural differentiation of induced EpiSCs.\
(J) N-CADHERIN and GFP immunostaining of the cells in (G).\
Ctrl, control (and similarly hereafter). Data are shown as means ± SEM of three independent experiments. Unpaired two-tailed Student\'s t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the control. Scale bars, 100 μm.](gr2){#fig2}

![RSV Inhibits the Neural Differentiation of mESCs in a SIRT1 Deacetylase Activity-Dependent Manner\
(A) RSV treatment causes an obvious decrease in acetylated H4K16 and H3K9 but does not alter phosphorylated GSK3β and ERK1/2, as shown by western blotting of day-1.5 and day-2.5 SFEBs.\
(B) SIRT1 deacetylase activity shows a dramatic increase upon RSV treatment in day-2.5 SFEBs.\
(C and D) SRT1720 treatment (1.5 μM) inhibits the neural differentiation of mESCs, as shown by microscopy (C) and qPCR (D) analysis in day-5 SFEBs.\
(E--H) *Sirt1* knockdown potentiates the RSV-suppressed neural induction efficiency, as shown by microscopy (E), FACS (F), qPCR (G), and immunostaining (H) analysis in day-5 SFEBs.\
(I--L) Ectopic expression of *Sirt1*, but not *Sirt1* H355A mutant, inhibits the neural differentiation of mESCs, as shown by microscopy (I), FACS (J), qPCR (K), and immunostaining (L) analysis in day-5 SFEBs.\
Data are shown as means ± SEM of three independent experiments. Unpaired two-tailed Student\'s t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the control; ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 versus the RSV-treated sh*Luc* group. Scale bars, 100 μm.](gr3){#fig3}

![SIRT1 Directly Targets OCT6 and Then Activates Its Deacetylation/Ubiquitination/Degradation Cascade\
(A and B) Overexpression of *Oct6*, but not *Sox2*, *Otx2*, or *Zic2*, ameliorates the RSV-induced neural induction defects, as shown by microscopy (A) and FACS (B) analysis.\
(C) qPCR confirmed the amelioration of neural induction defects via Oct6 overexpression.\
(D and E) OCT6 protein (E), rather than *Oct6* mRNA (D), is downregulated after RSV treatment during neural induction.\
(F) OCT6 enrichment in the enhancer regions of *Zfp521* and *Pax6* is greatly compromised in RSV-treated day-2.5 SFEBs.\
(G) *Sirt1* knockdown elevates OCT6 protein levels in mESCs.\
(H) *Sirt1* knockdown rescues the downregulation of OCT6 protein expression in RSV-treated day-2.5 SFEBs.\
(I) Overexpression of *Sirt1*, but not *Sirt1* H355A mutant, downregulates OCT6 protein levels in day-2.5 SFEBs.\
(J) MG132 pretreatment stabilizes OCT6 protein in RSV-treated day-2.5 SFEBs.\
(K and L) Immunoprecipitation of MG132-pretreated SFEBs with anti-Ac-Lys (K) or anti-OCT6 (L), followed by blotting with anti-OCT6 (K) and anti-ubiquitin (L).\
(M) SIRT1 endogenously interacts with OCT6 in day-2.5 SFEBs.\
(N) HA-tagged OCT6 directly interacts with FLAG-tagged SIRT1 or SIRT1 H355A when co-transfected into HEK 293FT cells.\
(O) The acetylation of OCT6 is decreased when SIRT1 is co-transfected into HEK 293FT cells compared with the SIRT1 H355A mutant.\
IP, immunoprecipitate; IB, immunoblot. Data are shown as means ± SEM of three independent experiments. Unpaired two-tailed Student\'s t test. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the control; ^\#^p \< 0.05, ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 versus the RSV-treated blank vector group. Scale bars, 100 μm.](gr4){#fig4}

![The SIRT1/OCT6 Axis Is Responsible for Environmental Stress-Induced Neural Induction Defects\
(A--C) H~2~O~2~ (0.4 mM), HU (0.4 μM), and glucose starvation hinder the neural induction of mESCs, as shown by microscopy (A), FACS (B), and qPCR (C) analysis of day-5 SFEBs.\
(D) SIRT1 deacetylase activity is significantly propagated under H~2~O~2~, HU, and glucose starvation conditions.\
(E) OCT6 protein is greatly downregulated under H~2~O~2~, HU, and glucose starvation conditions.\
(F and G) *Sirt1* knockdown rescues the neural induction defects triggered by H~2~O~2~, HU, and glucose starvation, as shown by FACS (F) and qPCR (G) analysis of day-5 SFEBs.\
(H and I) *Oct6* overexpression rescues the neural induction defects triggered by H~2~O~2~, HU, and glucose starvation, as shown by FACS (H) and qPCR (I) analysis of day-5 SFEBs.\
Data are shown as means ± SEM of three independent experiments. Unpaired two-tailed Student\'s t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the untreated control; ^\#^p \< 0.05, ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 versus the sh*Luc* group (F and G) or the blank vector group (H and I) under the same challenge conditions. Scale bars, 100 μm.](gr5){#fig5}

![Environmental Stresses Equally Target the SIRT1/OCT6 Axis and Hinder Neural Induction of hESCs\
(A--C) RSV treatment (30 μM) hinders the neural differentiation of hESCs, as shown by the reduced expression of *N-cadherin*, *Sox1*, *Nestin*, and *Sox2*, which were verified by immunostaining (A and B) and qPCR (C) analysis at day 10 of differentiation.\
(D) SIRT1 deacetylase activity is elevated by RSV treatment at day 5.\
(E) RSV treatment induces OCT6 downregulation at day 5 and day 6.\
(F) *Sirt1* knockout elevates OCT6 protein levels at day 3.\
(G) *Sirt1* knockout potentiates the neural differentiation of hESCs, as verified by the increased mRNA levels of neural-lineage genes at day 10.\
(H) *Sirt1* knockout rescues the downregulation of OCT6 protein levels induced by RSV treatment at day 5.\
(I) *Sirt1* knockout rescues the neural induction defects induced by RSV treatment, as verified by the mRNA levels of neural-lineage genes at day 10.\
(J) Overexpression of *Sirt1* hinders the neural differentiation of hESCs, as shown by the reduced levels of neural-lineage genes at day 10.\
(K) H~2~O~2~ (0.1 mM), HU (0.4 μM), and glucose starvation hinder the neural differentiation of hESCs, as shown by the reduced levels of neural-lineage genes at day 10.\
Data are shown as means ± SEM of three independent experiments. Unpaired two-tailed Student's t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the control; ^\#^p \< 0.05, ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 versus the RSV-treated wild-type hESC group. Scale bars, 100 μm.](gr6){#fig6}

![The Functional Role of the SIRT1/OCT6 Axis in Environmental Stress-Induced Neural Induction Defect during Early Embryogenesis\
(A and B) Immunostaining of SIRT1 and OCT6 in GD3.5 (A) and GD6.5 (B) embryos. EPI, epiblast; EXE, extraembryonic ectoderm; PL, placenta.\
(C) OCT6 protein levels in GD6.5 wild-type and *Sirt1*^+/−^ embryos.\
(D) The incidence of NTD-like phenotypes in GD10.5 *Sirt1*^+/−^ embryos or brain-specific (*Nestin-Cre*) *Sirt1*^+/−^ embryos after maternal RSV administration.\
(E) OCT6 protein levels in wild-type or *Sirt1*^+/−^ embryos with or without maternal RSV administration.\
(F) The incidence of NTD-like phenotypes in GD10.5 embryos after applying RSV administration from different gestational days.\
(G) The physical interaction between SIRT1 and OCT6 in GD6.5 embryos. IgG, immunoglobulin G; IB, immunoblot.\
(H) The incidence of NTD-like phenotypes in GD10.5 wild-type or *Sirt1*^+/−^ embryos with or without 4 Gy radiation at GD5.5.\
(I) OCT6 protein levels in GD6.5 wild-type or *Sirt1*^+/−^ embryos with or without radiation.\
(J) Schematic representation of the role of SIRT1 in sensing environmental stresses and antagonizing neural induction by deacetylating OCT6 and inducing its ubiquitination/degradation.\
Data were analyzed by Chi-square test. n.s. (not significant), p \> 0.05; ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 versus the untreated control; ^\#^p \< 0.05, ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 versus the RSV-treated wild-type embryos (D), RSV administration from GD6.5 to GD10.5 (F), and radiation-treated wild-type embryos (H). Scale bars, 50 μm.](gr7){#fig7}
